Free Trial

ADC Therapeutics (ADCT) SEC Filings & 10K Form

ADC Therapeutics logo
$3.62 -0.06 (-1.50%)
Closing price 06/13/2025 03:59 PM Eastern
Extended Trading
$3.61 -0.01 (-0.14%)
As of 06/13/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent ADC Therapeutics SEC Filings

DateFilerForm TypeView
06/13/2025
5:00 PM
ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
8:01 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2025
4:12 PM
ADC Therapeutics (Issuer)
Sandor Victor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
4:13 PM
ADC Therapeutics (Issuer)
COUGHLIN TIMOTHY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
6:40 PM
ADC Therapeutics (Subject)
HPWH TH AG (Filed by)
Form SCHEDULE 13G/A
05/14/2025
7:14 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
8:14 PM
ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2025
9:50 AM
ADC Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G/A
04/21/2025
8:20 AM
ADC Therapeutics (Filer)
Form DEFA14A
04/21/2025
8:20 AM
ADC Therapeutics (Filer)
Form DEF 14A
04/09/2025
11:07 AM
ADC Therapeutics (Filer)
Form PRE 14A
03/27/2025
2:28 PM
ADC Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/27/2025
2:34 PM
ADC Therapeutics (Filer)
Form ARS
03/27/2025
6:39 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
5:20 PM
ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:21 PM
ADC Therapeutics (Issuer)
Carmona Jose (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:22 PM
ADC Therapeutics (Issuer)
Kallebo Lisa Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:22 PM
ADC Therapeutics (Issuer)
Zaki Mohamed (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:23 PM
ADC Therapeutics (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
5:10 PM
ADC Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G
01/13/2025
11:20 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
8:00 PM
ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:37 PM
ADC Therapeutics (Issuer)
Carmona Jose (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:39 PM
ADC Therapeutics (Issuer)
Kallebo Lisa Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:42 PM
ADC Therapeutics (Issuer)
Zaki Mohamed (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:35 PM
ADC Therapeutics (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:30 PM
ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
8:00 PM
ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:00 PM
ADC Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G/A
11/13/2024
3:13 PM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
7:58 AM
ADC Therapeutics (Subject)
Prosight Management, LP (Filed by)
Form SC 13G/A
11/13/2024
7:30 AM
ADC Therapeutics (Subject)
Prosight Management, LP (Filed by)
Form SC 13G/A
11/07/2024
9:44 AM
ADC Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:54 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:35 PM
ADC Therapeutics (Filer)
Form DEF 14A
09/23/2024
3:39 PM
ADC Therapeutics (Filer)
Form DEFA14A
08/13/2024
11:15 PM
ADC Therapeutics (Filer)
Form EFFECT
08/06/2024
3:26 PM
ADC Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/06/2024
9:06 AM
ADC Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2024
6:37 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
7:00 PM
ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Why July 22nd Could Mean Big Changes for Social Security (Ad)

In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Social Security — and his plan is set to roll out July 22. What's coming next isn't about trimming waste.

To see the full playbook and how it could impact everyone, click here.
06/18/2024
8:40 PM
ADC Therapeutics (Issuer)
Monges Viviane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:41 PM
ADC Therapeutics (Issuer)
Hug Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:43 PM
ADC Therapeutics (Issuer)
BIZZARI JEAN-PIERRE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:45 PM
ADC Therapeutics (Issuer)
Azelby Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:29 PM
ADC Therapeutics (Subject)
Azelby Robert (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
8:30 PM
ADC Therapeutics (Subject)
Squarer Ron (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
8:35 PM
ADC Therapeutics (Issuer)
Squarer Ron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:37 PM
ADC Therapeutics (Issuer)
Sandor Victor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:38 PM
ADC Therapeutics (Issuer)
Pfisterer Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:26 PM
ADC Therapeutics (Subject)
BIZZARI JEAN-PIERRE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
8:28 PM
ADC Therapeutics (Subject)
Sandor Victor (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
4:44 PM
ADC Therapeutics (Issuer)
BIZZARI JEAN-PIERRE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:46 PM
ADC Therapeutics (Issuer)
Azelby Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:37 PM
ADC Therapeutics (Issuer)
Pfisterer Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:40 PM
ADC Therapeutics (Issuer)
Hug Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:23 PM
ADC Therapeutics (Issuer)
Monges Viviane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:25 PM
ADC Therapeutics (Issuer)
Squarer Ron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:29 PM
ADC Therapeutics (Issuer)
Sandor Victor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:ADCT) was last updated on 6/15/2025 by MarketBeat.com Staff
From Our Partners